SPADARO, Aldo
 Distribuzione geografica
Continente #
NA - Nord America 959
EU - Europa 765
AS - Asia 146
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
SA - Sud America 1
Totale 1.873
Nazione #
US - Stati Uniti d'America 954
IE - Irlanda 243
SE - Svezia 234
CN - Cina 125
UA - Ucraina 105
DE - Germania 65
GB - Regno Unito 43
FI - Finlandia 37
BE - Belgio 18
IT - Italia 17
IN - India 10
SG - Singapore 9
CA - Canada 5
RU - Federazione Russa 2
CL - Cile 1
ES - Italia 1
EU - Europa 1
IR - Iran 1
NZ - Nuova Zelanda 1
TR - Turchia 1
Totale 1.873
Città #
Dublin 243
Jacksonville 214
Chandler 176
Nyköping 127
Beijing 82
Ashburn 70
Ann Arbor 67
Cambridge 38
Princeton 37
Des Moines 31
Medford 30
Lancaster 26
Boardman 23
Dearborn 22
Woodbridge 20
Brussels 18
Los Angeles 18
San Mateo 12
Pune 10
Jinan 9
Singapore 6
Mountain View 5
Haikou 4
Changsha 3
Ningbo 3
Norwalk 3
Salerno 3
Taizhou 3
Washington 3
Wilmington 3
Auburn Hills 2
Bolzano 2
Cene 2
Chicago 2
Hangzhou 2
Messina 2
Nanchang 2
Nanjing 2
Ottawa 2
Seattle 2
Shenyang 2
Taiyuan 2
Zhengzhou 2
Ardabil 1
Auckland 1
Boston 1
Bremen 1
Chongqing 1
Fort Payne 1
Fuzhou 1
Granby 1
Guangzhou 1
Hefei 1
Lanzhou 1
Laval 1
Milan 1
Montréal 1
Palermo 1
Phoenix 1
Saint Louis 1
Tianjin 1
Totale 1.353
Nome #
Low utility of plasma Nociceptin/orphanin FQ in the diagnosis of hepatocellular carcinoma 86
Class I HLA antigens hepatic display and beta-2-microglobulin serum values in chronic hepatitis C: Effect of treatment with recombinant alpha interferon 80
High serum resistin in chronic viral hepatitis is not a marker of metabolic disorder. 80
High Serum Resistin in Chronic Viral Hepatitis Is not a Marker of Metabolic Disorder 79
Serum thrombopoietin in chronic liver disease: Relation to severity of the disease and spleen size 75
Randomised trial of two different daily doses of interferon- alpha versus classical therapy in treatment-naive patients with chronic hepatitis C 68
Efficacy of interferon treatment (IFN) in elderly patients with chronic hepatitis C 63
Interferon retreatment of patients with chronic hepatitis C. A long-term follow-up 56
FOCAL LYMPHOCYTIC AGGREGATES IN CHRONIC HEPATITIS-C - OCCURRENCE, IMMUNOHISTOCHEMICAL CHARACTERIZATION, AND RELATION TO MARKERS OF AUTOIMMUNITY 55
[Behavior of anti-HBc IgM in acute and chronic hepatitis]. 54
A randomized trial of peginterferon alpha-2a with or without ribavirin for HBeAg-negative chronic hepatitis B. 53
Ten year follow-up of patients with chronic hepatitis C treated with interferon 52
HCV INFECTION, HEPATIC HLA DISPLAY AND COMPOSITION OF THE MONONUCLEAR CELL INFLAMMATORY INFILTRATE IN CHRONIC-ALCOHOLIC LIVER-DISEASE 52
Serum chromogranin-A in hepatocellular carcinoma: diagnostic utility and limits. 51
Antibodies to hepatitis A virus in Italian patients with chronic liver disease 49
Retreatment with interferon plus ribavirin of chronic hepatitis C non-responders to interferon monotherapy: a meta-analysis of individual patient data 48
Farmaci di più comune uso in gastroenterologia 48
Current practice of hepatitis C treatment in Southern Italy. 48
Clinical Outcome of HBeAg-Negative Chronic Hepatitis B in Relation to Virological Response to Lamivudine 47
Prognostic factors of survival in complicated viral and alcoholic cirrhosis without hepatocellular carcinoma. A retrospective study. 47
Does malnutrition affect survival in cirrhosis? 47
PREVALENCE OF ANTI-HCV ANTIBODIES IN PATIENTS WITH CHRONIC LIVER-DISEASE AND ITS RELATIONSHIP TO HBV AND HDV INFECTIONS 47
Toxicity of IFN plus ribavirin in patients with chronic hepatitis C. A multicenter retrospective study 46
Premature discontinuation of interferon plus ribavirin for adverse effects: a multicentre survey in 'real world' patients with chronic hepatitis C 46
High circulating D-dimers are associated with ascites and hepatocellularcarcinoma in liver cirrhosis. 46
Cultural representation of newborn feeding 45
NON-ALCOHOLIC FATTY LIVER DISEASE: A MULTICENTRE CLINICAL STUDY BY THE ITALIAN ASSOCIATION FOR THE STUDY OF THE LIVER 44
Terapia dell'epatite cronica C: 10 anni di esperienze 43
Re-treatment with interferon plus ribavirin of chronic hepatitis C nonresponders to interferon monotherapy: A meta- analysis of individual patient data 41
FULMINANT HEPATIC FAILURE AND AUTOIMMUNE DISORDERS IN PATIENT WITH MULTIPLE SCLEROSIS ON INTERFERON BETA 1A: A FATAL COMBINATION? 41
Soluble CD30 serum levels before and after treatment with alpha-interferon in patients with chronic hepatitis 40
High circulating D-dimers are associated with ascites and hepatocellular carcinoma in liver cirrhosis. 39
Low utility of plasma Nociceptin/orphanin FQ in the diagnosis of hepatocellular carcinoma. 37
Randomized trial of two different daily doses of alpha-interferon versus classical treatment in naive patients with chronic hepatitis C 34
Current practice of chronic hepatitis B treatment in Southern Italy. 34
Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: A randomized controlled trial. 30
Current practice of hepatitis C treatment in Southern Italy. 30
Totale 1.881
Categoria #
all - tutte 7.179
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.179


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020282 0 29 2 28 1 24 42 33 4 66 51 2
2020/2021238 35 2 50 15 5 36 2 28 3 30 17 15
2021/2022240 2 30 5 14 14 3 8 7 4 42 41 70
2022/2023698 48 64 51 35 62 66 7 52 284 5 19 5
2023/2024161 7 32 10 21 16 45 8 16 0 1 0 5
2024/202520 4 16 0 0 0 0 0 0 0 0 0 0
Totale 1.881